Home UNII UYE4T5I70X DEXLANSOPRAZOLE Substance profile for UNII UYE4T5I70X, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 9578005 Substance Identity#
UNII UYE4T5I70X
Preferred term DEXLANSOPRAZOLE
Registry number 138530-94-6
Ingredient type INGREDIENT SUBSTANCE
Molecular formula C16H14F3N3O2S Structure render from PubChem CID 9578005 Chemical And Database Identifiers#
InChIKey MJIHNNLFOKEZEW-RUZDIDTESA-N
SMILES CC1=C(OCC(F)(F)F)C=CN=C1C[S@@+]([O-])C2=NC3=C(N2)C=CC=C3
RxCUI 816346
PubChem 9578005
NCIt C73192
INN ID 8524
DailyMed Socrata Ingredients# Type, DailyMed label, SPL version table Type DailyMed label SPL version ACTIVE MOIETY These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole) 2 ACTIVE INGREDIENT These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole) 2 ACTIVE INGREDIENT c83616c9-c222-4e3e-91bd-c7839406bb2a 1 ACTIVE MOIETY c83616c9-c222-4e3e-91bd-c7839406bb2a 1 ACTIVE INGREDIENT DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] 17 ACTIVE MOIETY DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] 17 ACTIVE INGREDIENT DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH] 3 ACTIVE MOIETY DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH] 3